The following categories are used to indicate the frequency of occurrence of adverse effects: Very common (≥1/10), Common (≥1/100 to <1/10), Uncommon (≥ 1/1,000 to <1/100), Rare (≥1/10,000 to <1/1,000), Very rare (<1/10,000), Unknown (Frequency not assessable based on the available data).
They are presented in the table as follows: See table.

Swelling face and allergic reactions, including application site hypersensitivity and anaphylaxis (unknown frequency) have been reported during postmarketing surveillance.
View ADR Reporting Link